trial
as of 2026-07-01Efficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental Disorders
NCTId NCT06112067
at a glance
— · Recruiting
Enrollment 18 (estimated)
Sponsored by Shanghai Mental Health Center
Primary completion 2026-08
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Recruiting
Enrollment
18 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2023-10-16
Primary completion
2026-08
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Shanghai Mental Health CenterLead Sponsor
SceneRay Corporation, LimitedCollaborator
Huashan HospitalCollaborator
Shanghai 6th People's HospitalCollaborator
Changhai HospitalCollaborator
Investigators
1
Zhen Wang, MD,PhDPrincipal Investigator
Sites
1 total
Shanghai, China
Facts & assertions
4 sourced
Enrollment
18
Phase
NA
Primary Completion Date
2026-08
Status
RECRUITING
relationships
The graph out of here
drug
lead_sponsor
collaborator
company
indication
investigator
person